Ameritas Investment Partners’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Ameritas Investment Partners’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,013	Closed	-$7.35K	–	3259
2024 Q1	$7.35K	Hold	2,013	–	–	﹤0.01%	2893
2023 Q4	$6.06K	Hold	2,013	–	–	﹤0.01%	2942
2023 Q3	$4.33K	Hold	2,013	–	–	﹤0.01%	3008
2023 Q2	$11.3K	Buy	+2,013	New	+$15.7K	﹤0.01%	2867
2022 Q2	–	Sell	-1,717	Closed	-$11K	–	3271
2022 Q1	$11K	Buy	1,717 +1,150	+203%	+$11.7K	﹤0.01%	2777
2021 Q4	$6K	Hold	567	–	–	﹤0.01%	3022
2021 Q3	$11K	Buy	+567	New	+$10.9K	﹤0.01%	2924

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ameritas Investment Partners's OMGA Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2024, closing a stake of 2,013 shares — an estimated $7.35K sold.

Ameritas Investment Partners first reported a position in OMGA in Q3 2021 and held it in 7 quarters. The position peaked at $11.3K in Q2 2023. 68 funds tracked by Wall St. Rank hold OMGA as of Q2 2024.

Ameritas Investment Partners reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 2,013 Omega Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $7.35K.
Ameritas Investment Partners first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Ameritas Investment Partners's Omega Therapeutics, Inc. Common Stock position peaked at $11.3K in Q2 2023.
68 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.